Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25531| Title: | Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics. | Austin Authors: | Scott, Andrew M ;Bodei, Lisa | Affiliation: | Memorial Sloan Kettering Cancer Center.. Austin Health |
Issue Date: | 2021 | Date: | 2020 | Publication information: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; 62(7): 884-885 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/25531 | DOI: | 10.2967/jnumed.120.254995 | Journal: | Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine | PubMed URL: | 33384321 | Type: | Journal Article | Subjects: | Molecular Biology Oncology: General Radionuclide Therapy mutations pharmacogenomics radionuclide therapy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.